Transaction · 0001562180-25-002202

MAHON PAUL A

MAHON PAUL A, EVP, GC, reported a transaction classified as return at UNITED THERAPEUTICS Corp involving 6550.000000 shares for an estimated $2015304.00. Reported holdings after the transaction were 36781.000000 shares. The stored filing text includes a detected 10b5-1 reference.

returnSEC transaction code DEVP, GC
UTHRUNITED THERAPEUTICS Corp
Filing timeMar 07
Trade dateMar 06, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

UTHR price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
UTHR since 2025-03-07Filed 546 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
return
Code D
Identifier
0001562180-25-002202
Common Stock
Transaction date
Mar 06, 2025
Filed Mar 07, 2025, 09:33 PM · 1d delay
Shares
6.55k sh
$30.7k per share
Estimated value
-$201M
Computed from shares × price
Holdings after
36.7k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

EVP & GENERAL COUNSEL

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    This is an exercise of share tracking awards pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on June 20, 2024. Share tracking awards are non-dilutive cash-settled stock app…

  2. converted into shares of common stock.

  3. F2

    Includes 71 shares of common stock acquired on March 4, 2025 under the United Therapeutics Employee Stock Purchase Plan.

  4. F3

    Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Original filing · 0001562180-25-002202
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

UTHR